Cargando…
Current advances in the treatment of giant cell arteritis: the role of biologics
Giant cell arteritis (GCA) is the most common form of systemic vasculitis. It is a potentially severe disease with 25% of patients suffering vision loss or stroke. Our treatment paradigm is based on glucocorticoids. Glucocorticoids are required in high doses for prolonged periods and subsequently ar...
Autores principales: | Low, Candice, Conway, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378487/ https://www.ncbi.nlm.nih.gov/pubmed/30800174 http://dx.doi.org/10.1177/1759720X19827222 |
Ejemplares similares
Cargando…
Cardiovascular lesions in giant cell arteritis
por: Dzhus, Marta, et al.
Publicado: (2022)
por: Dzhus, Marta, et al.
Publicado: (2022)
Ejemplares similares
-
Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica
por: Low, Candice, et al.
Publicado: (2023) -
Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021) -
Advances in the Treatment of Giant Cell Arteritis
por: Castañeda, Santos, et al.
Publicado: (2022) -
Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020) -
Treatment of Giant Cell Arteritis (GCA)
por: Régent, Alexis, et al.
Publicado: (2022)